Status:

ACTIVE_NOT_RECRUITING

Transcranial Photobiomodulation With Near-Infrared Light for Language in Individuals With Down Syndrome

Lead Sponsor:

Massachusetts General Hospital

Conditions:

Down Syndrome

Eligibility:

All Genders

16-35 years

Phase:

NA

Brief Summary

The aim of this study is to better understand the effects of transcranial photobiomodulation (tPBM) on neural oscillations of individuals diagnosed with Down syndrome.

Detailed Description

This study will compare the effect of tPBM to sham tPBM on gamma neural oscillations in the brain as assessed by EEG, and on language, attention and memory as assessed by neuropsychological testing. P...

Eligibility Criteria

Inclusion

  • Inclusion criteria for this study include:
  • adult men and women between the ages of 16 and 35
  • diagnosis of DS (i.e., clinical diagnosis of Trisomy 21 or Complete Unbalanced Translocation of Chromosome 21)
  • Exclusion criteria for this study include:
  • diagnosis of seizure disorder
  • diagnosis of dementia
  • inability to complete study procedures
  • English as a second language
  • speech as the secondary mode of communication
  • speech of less than two-word utterances
  • changes in medications, augmentative devices, and other intervention two weeks prior to baseline testing and throughout study completion at PI's discretion
  • untreated obstructive sleep apnea (OSA)
  • Participation in other clinical research trials that may influence affect primary outcomes or adherence to the proposed study, as assessed by the PI and the Co-Is
  • candidates who have a current diagnosis of cancer and/or are currently undergoing treatment for cancer
  • history of migraine with an aura in the past 6 months
  • current pregnancy

Exclusion

    Key Trial Info

    Start Date :

    October 19 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    September 1 2024

    Estimated Enrollment :

    19 Patients enrolled

    Trial Details

    Trial ID

    NCT04668001

    Start Date

    October 19 2021

    End Date

    September 1 2024

    Last Update

    May 31 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Massachusetts General Hospital at the Charlestown Navy Yard

    Charlestown, Massachusetts, United States, 02129